Deranged early T cell development in immunodeficient strains of nonobese diabetic mice

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5381-5391

  Yui, Mary A ^a   Rothenberg, Ellen V ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; PROTEIN BCL 2; PROTEIN BCL XL; RAG1 PROTEIN; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR CALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HEB ALT; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR SPI B; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DOWN REGULATION; GENE EXPRESSION; GENE REARRANGEMENT; HYBRID; IMMUNE DEFICIENCY; MOSAICISM; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE; THYMUS;

EID: 6344272486     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5381     Document Type: Article

References (52)

1. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
2. Todd, J. A., and L. S. Wicker. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15:387.
3. Serreze, D. V., and E. H. Leiter. 2001. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4:31.
4. Berzins, S. P., E. S. Venanzi, C. Benoist, and D. Mathis. 2003. T-cell compartments of prediabetic NOD mice. Diabetes 52:327.
5. Garchon, H. J., J. J. Luan, L. Eloy, P. Bedossa, and J. F. Bach. 1994. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur. J. Immunol. 24:380.
6. Colucci, F., C. M. Cilio, K. Lejon, C. P. Goncalves, M. L. Bergman, and D. Holmberg. 1996. Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J. Autoimmun. 9:271.
7. Leijon, K., B. Hammarstrom, and D. Holmberg. 1994. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int. Immunol. 6:339.
8. Lamhamedi-Cherradi, S. E., J. J. Luan, L. Eloy, G. Fluleau, J. F. Bach, and H. J. Garchon. 1998. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 41:178.
9. Zipris, D., A. H. Lazarus, A. R. Crow, M. Hadzija, and T. L. Delovitch. 1991. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 146:3763.
10. Penha-Goncalves, C., K. Leijon, L. Persson, and D. Holmberg. 1995. Type 1 diabetes and the control of dexamethasone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 28:398.
11. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2:1025.
12. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989.
13. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46:572.
14. -/- and SCID thymocytes on two genetic backgrounds: developmental choices and cell death mechanisms before TCR gene rearrangement. J. Immunol. 158:4052.
15. Kruisbeek, A. M., M. C. Haks, M. Carleton, A. M. Michie, J. C. Zuniga-Pflucker, and D. L. Wiest. 2000. Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol. Today 21:637.
16. Rothenberg, E. V., M. A. Yui, and J. C. Telfer. 2003. T-cell developmental biology. In Fundamental Immunology. W. E. Paul, ed. Lippincott Williams & Wilkins, Philadelphia, p. 259.
17. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89:3290.
18. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180.
19. Shultz, L. D., P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al. 2000. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164:2496.
20. Yui, M. A., G. Hernandez-Hoyos, and E. V. Rothenberg. 2001. A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J. Immunol. 166:1730.
21. Chiu, P. P., E. Ivakine, S. Mortin-Toth, and J. S. Danska. 2002. Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice. Cancer Res. 62:5828.
22. Gratiot-Deans, J., R. Merino, G. Nunez, and L. A. Turka. 1994. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl. Acad. Sci. USA 91:10685,
23. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1:197.
24. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973,
25. Grusby, M. J., H. Auchincloss, Jr., R. Lee, R. S. Johnson, J. P. Spencer, M. Zijlstra, R. Jaenisch, V. E. Papaioannou, and L. H. Glimcher. 1993. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. USA 90:3913.
26. lck. EMBO J. 11:4877.
27. - murine thymocytes: in vivo developmental kinetics and T cell receptor β chain rearrangement status. J. Exp. Med. 177:1079.
28. Petrie, H. T., M. Tourigny, D. B. Burtrum, and F. Livak. 2000. Precursor thymocyte proliferation and differentiation are controlled by signals unrelated to the pre-TCR. J. Immunol. 165:3094.
29. Di Santo, J. P., I. Aifantis, E. Rosmaraki, C. Garcia, J. Feinberg, H. J. Fehling, A. Fischer, H. von Boehmer, and B. Rocha. 1999. The common cytokine receptor γ chain and the pre-T cell receptor provide independent but critically overlapping signals in early α/β T cell development. J. Exp. Med. 189:563.
30. Anderson, M. K., G. Hernandez-Hoyos, R. A. Diamond, and E. V. Rothenberg. 1999. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131.
31. Winandy, S., L. Wu, J. H. Wang, and K. Georgopoulos. 1999. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190:1039.
32. Hernandez-Hoyos, G., M. K. Anderson, C. Wang, E. V. Rothenberg, and J. Alberola-Ila. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19:83.
33. Pai, S. Y., M. L. Truitt, C. N. Ting, J. M. Leiden, L. H. Glimcher, and I. C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863.
34. Jacobs, H., P. Krimpenfort, M. Haks, J. Allen, B. Blom, C. Demolliere, A. Kruisbeek, H. Spits, and A. Berns. 1999. PIM1 reconstitutes thymus cellularity in interleukin 7- and common γ chain-mutant mice and permits thymocyte maturation in Rag- but not CD3γ-deficient mice. J. Exp. Med. 190:1059.
35. + stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 183:1923.
36. Bogue, M. A., C. Zhu, E. Aguilar-Cordova, L. A. Donehower, and D. B. Roth. 1996. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10:553.
37. Levelt, C. N., A. Ehrfeld, and K. Eichmann. 1993. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3ε determines clonal deletion or induction of developmental program. J. Exp. Med. 177:707.
38. Schmedt, C., and A. Tarakhovsky. 2001. Autonomous maturation of α/β T lineage cells in the absence of COOH-terminal Src kinase (Csk). J. Exp. Med. 193:815.
39. Mombaerts, P., S. J. Anderson, R. M. Perlmutter, T. W. Mak, and S. Tonegawa. 1994. An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1:261.
40. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621.
41. Chi, T. H., M. Wan, K. Zhao, I. Taniuchi, L. Chen, D. R. Littman, and G. R. Crabtree. 2002. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418:195.
42. Guidos, C. J., C. J. Williams, I. Grandal, G. Knowles, M. T. Huang, and J. S. Danska. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10:2038.
43. Voll, R. E., E. Jimi, R. J. Phillips, D. F. Barber, M. Rincon, A. C. Hayday, R. A. Flavell, and S. Ghosh. 2000. NF-κB activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13:677.
44. Newton, K., A. W. Harris, and A. Strasser. 2000. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19:931.
45. Ridgway, W. M., M. Fasso, A. Lanctot, C. Garvey, and C. G. Fathman. 1996. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183:1657.
46. Leiter, E. 1998. NOD mice and related strains: origins, husbandry and biology introduction. In NOD Mice and Related Strains: Research Applications in Diabetes, AIDs, Cancer and Other Diseases. E. Leiter, and M. Atkinson, eds. R. G. Landes, Austin, p. 37.
47. Harker, N., T. Naito, M. Cortes, A. Hostert, S. Hirschberg, M. Tolaini, K. Roderick, K. Georgopoulos, and D. Kioussis. 2002. The CD8α gene locus is regulated by the Ikaros family of proteins. Mol. Cell 10:1403.
48. Schotte, R., M. C. Rissoan, N. Bendriss-Vermare, J. M. Bridon, T. Duhen, K. Weijer, F. Briere, and H. Spits. 2003. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. Blood 101:1015.
49. Bachmann, M. F., M. Barner, and M. Kopf. 1999. CD2 sets quantitative thresholds in T cell activation. J. Exp. Med. 190:1383.
50. Sasada, T., and E. L. Reinherz. 2001. A critical role for CD2 in both thymic selection events and mature T cell function. J. Immunol. 166:2394.
51. null NOD-scid mice: an improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 44:1392.
52. Engel, I., and C. Murre. 2002. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc. Natl. Acad. Sci. USA 99:11322.